Poly Medicure Limited
Simbol: POLYMED.NS
NSE
1585.05
INRTržna cena danes
61.3484
Razmerje P/E
311.8541
Razmerje PEG
152.12B
Kapaciteta MRK
- 0.00%
Donos DIV
Poly Medicure Limited (POLYMED-NS) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3090.3 | 3516.7 | 3742.7 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 3019.7 | 3439.1 | 3693.1 | |||||||||||||||||
balance-sheet.row.net-receivables | 0 | 2357.3 | 2403.3 | 1884.5 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 2086.5 | 1683.6 | 1264.8 | |||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 535.9 | 230.7 | 165.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 8070.1 | 7834.4 | 7057.8 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 6623.8 | 4769.7 | 3910.2 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 285.8 | 285.8 | 285.8 | |||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 215.5 | 220.7 | 228.3 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 501.3 | 506.6 | 514.1 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 89.7 | 204.2 | 508.6 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 109.1 | 453.6 | 165.5 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 378.1 | 0 | 81.1 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 7702 | 5934 | 5179.5 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 0 | 15772.1 | 13768.3 | 12237.3 | |||||||||||||||||
balance-sheet.row.account-payables | 0 | 923.1 | 890.4 | 645.2 | |||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1301.7 | 882 | 721.8 | |||||||||||||||||
balance-sheet.row.tax-payables | 0 | 8.4 | 0 | 7.1 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 188.5 | 385.1 | 652.4 | |||||||||||||||||
Deferred Revenue Non Current | 0 | 27.4 | 35.3 | 43.3 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 328.5 | 230.7 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 422.8 | 626.8 | 867.6 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 25.8 | 14.3 | 32.9 | |||||||||||||||||
balance-sheet.row.total-liab | 0 | 3355.8 | 2893.5 | 2581.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 0 | 479.7 | 479.5 | 479.4 | |||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 5277.5 | 3990.4 | 3041.7 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2730.4 | 2486.2 | 2216.2 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 3928.7 | 3918.7 | 3918.5 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 12416.3 | 10874.8 | 9655.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 15772.1 | 13768.3 | 12237.3 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 0 | 12416.3 | 10874.8 | 9655.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||
Total Investments | 0 | 189.7 | 286 | 578.3 | |||||||||||||||||
balance-sheet.row.total-debt | 0 | 1490.2 | 1267.1 | 1374.3 | |||||||||||||||||
balance-sheet.row.net-debt | 0 | 1419.5 | 1189.5 | 1324.7 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 2374.9 | 1952.4 | 1800.5 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 571.7 | 539.5 | 475.2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -602 | -623.2 | -530.3 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 19.3 | 9.3 | 6.5 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -499.6 | -633.9 | -611.9 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | -288 | -507.4 | -332.3 | |||||||||||||||||
cash-flows.row.inventory | 0 | -402.9 | -418.8 | -143.9 | |||||||||||||||||
cash-flows.row.account-payables | 0 | 37.7 | 247 | 0.6 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 153.6 | 45.2 | -136.3 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 44 | -9.5 | 47.2 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2392.7 | -1555.8 | -951.3 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.5 | 15.1 | 6.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -579.1 | -660.6 | -3444.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 577.6 | 645.4 | -6.1 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 602.6 | 702.5 | 39.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1790.2 | -853.3 | -4355.8 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -209.9 | -62.8 | -664.5 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 3.5 | 1 | 4000 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -209.9 | 62.8 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -239.7 | -239.2 | 0 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 531 | -115.2 | -166 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -125.1 | -353.4 | 3169.5 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -7 | 28 | 1 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 70.6 | 77.6 | 49.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 77.6 | 49.5 | 48.6 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 1908.3 | 1234.7 | 1187.3 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -2392.7 | -1555.8 | -951.3 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -484.5 | -321.1 | 236 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 11152.3 | 9168.9 | 7750.4 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 4058.8 | 4332.3 | 3364.6 | |||||||||||||||||
income-statement-row.row.gross-profit | 0 | 7093.6 | 4836.6 | 4385.7 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | 361.9 | 35.5 | 12.3 | |||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 5011.4 | 3195 | 2683.1 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 9070.1 | 7527.3 | 6047.8 | |||||||||||||||||
income-statement-row.row.interest-income | 0 | 59.7 | 22.9 | 33.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 88.4 | 37.2 | 77.4 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 287.4 | 356.2 | 132 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 361.9 | 35.5 | 12.3 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 287.4 | 356.2 | 132 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 88.4 | 37.2 | 77.4 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 571.7 | 539.5 | 475.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 0 | 2087.5 | 1596.2 | 1668.6 | |||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 2374.9 | 1952.4 | 1800.5 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 582.1 | 487.4 | 441.8 | |||||||||||||||||
income-statement-row.row.net-income | 0 | 1792.8 | 1465.1 | 1358.7 |
Pogosto zastavljeno vprašanje
Kaj je Poly Medicure Limited (POLYMED.NS) skupna sredstva?
Poly Medicure Limited (POLYMED.NS) skupna sredstva so 15772092000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.650.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 10.150.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.191.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.248.
Kaj je Poly Medicure Limited (POLYMED.NS) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 1792825000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 1490168000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 5011373000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.